Precision Optics (PEYE) vs. SpectraScience (SCIE) Financial Comparison
Precision Optics (OTCMKTS:PEYE) and SpectraScience (OTCMKTS:SCIE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.
This table compares Precision Optics and SpectraScience’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Precision Optics has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500. Comparatively, SpectraScience has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500.
Insider and Institutional Ownership
0.0% of SpectraScience shares are owned by institutional investors. 24.7% of Precision Optics shares are owned by insiders. Comparatively, 0.5% of SpectraScience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Precision Optics and SpectraScience’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Precision Optics||$4.04 million||3.80||-$350,000.00||N/A||N/A|
Precision Optics has higher revenue and earnings than SpectraScience.
This is a breakdown of recent ratings and target prices for Precision Optics and SpectraScience, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
SpectraScience beats Precision Optics on 5 of the 8 factors compared between the two stocks.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use. The company markets its products to original equipment manufacturers through medical device companies. Precision Optics Corporation, Inc. has collaboration with OmniVision Technologies, Inc. to develop optical solutions based on an image sensor integrated with its lenses. The company was founded in 1982 and is based in Gardner, Massachusetts.
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. It offers WavSTAT3 optical biopsy system to determine whether a colon tissue is normal, pre-cancerous, or cancerous without physically removing tissue from the body; and WavSTAT4 optical biopsy system, a colon diagnostic product that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells mobile consoles and disposable forceps. In addition, it engages in developing an esophageal diagnosis application for the detection of pre-cancerous and cancerous tissues in various tissues of the body. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.